These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20017580)

  • 1. The in chemico-in silico interface: challenges for integrating experimental and computational chemistry to identify toxicity.
    Cronin MT; Bajot F; Enoch SJ; Madden JC; Roberts DW; Schwöbel J
    Altern Lab Anim; 2009 Nov; 37(5):513-21. PubMed ID: 20017580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of mechanisms and modes of toxic action in integrated testing strategies: the report and recommendations of a workshop held as part of the European Union OSIRIS Integrated Project.
    Vonk JA; Benigni R; Hewitt M; Nendza M; Segner H; van de Meent D; Cronin MT
    Altern Lab Anim; 2009 Nov; 37(5):557-71. PubMed ID: 20017584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico toxicology challenges for pharmaceuticals: complacency or controversy?
    Cronin MT
    Altern Lab Anim; 2009 Nov; 37(5):453-6. PubMed ID: 20017576
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology is IN: in silico, in vitro, integrated testing strategy.
    Caloni F; Benfenati E; Sambuy Y
    ALTEX; 2016; 33(2):187-8. PubMed ID: 27032091
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept case.
    Jaworska J; Harol A; Kern PS; Gerberick GF
    ALTEX; 2011; 28(3):211-25. PubMed ID: 21993957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro methods and safety testing of chemicals].
    Louekari K; Salminen L; Tähti H
    Duodecim; 1998; 114(9):851-8. PubMed ID: 11524804
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrated testing strategy (ITS) for bioaccumulation assessment under REACH.
    Lombardo A; Roncaglioni A; Benfentati E; Nendza M; Segner H; Fernández A; Kühne R; Franco A; Pauné E; Schüürmann G
    Environ Int; 2014 Aug; 69():40-50. PubMed ID: 24806447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated testing strategies for use with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():7-27. PubMed ID: 19025329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and Future Perspectives on the Development, Evaluation, and Application of in Silico Approaches for Predicting Toxicity.
    Patlewicz G; Fitzpatrick JM
    Chem Res Toxicol; 2016 Apr; 29(4):438-51. PubMed ID: 26686752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity.
    Aptula AO; Roberts DW
    Chem Res Toxicol; 2006 Aug; 19(8):1097-105. PubMed ID: 16918251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated decision-tree testing strategy for repeat dose toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):93-101. PubMed ID: 18333717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food for thought ... on alternative methods for cosmetics safety testing.
    Hartung T
    ALTEX; 2008; 25(3):147-62. PubMed ID: 18841313
    [No Abstract]   [Full Text] [Related]  

  • 14. The way forward in reproductive/developmental toxicity testing.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico toxicology in drug discovery - concepts based on three-dimensional models.
    Vedani A; Smiesko M
    Altern Lab Anim; 2009 Nov; 37(5):477-96. PubMed ID: 20017578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing alternatives to systemic toxicity testing approaches.
    von Aulock S
    ALTEX; 2012; 29(1):1. PubMed ID: 22408846
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of predictivity of the rat lethality (LD50) test for ecological and human health effects.
    Rosenkranz HS; Cunningham AR
    Altern Lab Anim; 2005 Feb; 33(1):9-19. PubMed ID: 15804213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein biomarkers for in vitro testing of toxicology.
    Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
    Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probabilistic hazard assessment for skin sensitization potency by dose-response modeling using feature elimination instead of quantitative structure-activity relationships.
    Luechtefeld T; Maertens A; McKim JM; Hartung T; Kleensang A; Sá-Rocha V
    J Appl Toxicol; 2015 Nov; 35(11):1361-1371. PubMed ID: 26046447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of an Integrated Testing Strategy consisting of in silico, in chemico and in vitro assays for evaluating the skin sensitization potencies of isocyanates.
    Ohtake T; Maeda Y; Hayashi T; Yamanaka H; Nakai M; Takeyoshi M
    Toxicology; 2018 Jan; 393():9-14. PubMed ID: 29100879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.